EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Proteomics in biopharmaceutical industries

Gabriel Padrón

Journal of Proteomics · 2026-06 · 328 · 105646

DOI: 10.1016/j.jprot.2026.105646 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Proteomics, 2026-06. Verfasst von Gabriel Padrón. Beteiligte Einrichtung: Center for Genetic Engineering and Biotechnology, PO Box 6162, La Habana, Cuba. Electronic address: gpadronpalomares@gmail.com. Hauptthemen laut MEDLINE: Proteomics, Drug Industry, Recombinant Proteins, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteomic tools have been integral to the biopharmaceutical industry since its inception, supporting both the discovery of new drugs and the production of recombinant therapeutic proteins. Mass spectrometry combined with liquid chromatography has proven to be an indispensable analytical approach for the characterization and analysis of therapeutic proteins. The relatively recent emergence of the Multi-Attribute Method, an advanced mass spectrometry-based analytical approach, is being increasingly incorporated in the biopharmaceutical industry for quality control and simultaneously monitor and quantify multiple quality attributes of therapeutic proteins, such as monoclonal antibodies and other biologics. The combination of Multi-Attribute Method with the analysis of intact proteins by mass spectrometry could replace the vast majority of traditional control techniques and become the essential platform to ensure the quality and safety of therapeutic proteins in the near future. SIGNIFICANCE: This review demonstrates the great importance of proteomics for the biopharmaceutical industry, both in the development of new drugs and in the production of recombinant proteins. Advances in mass spectrometry, along with liquid chromatography, will soon become a fundamental tool for quality control of therapeutic proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsDrug IndustryRecombinant ProteinsBiological ProductsHumansMass SpectrometryAntibodies, MonoclonalLiquid Chromatography-Mass SpectrometryAnimalsQuality Control

Stichwörter der Autor:innen

Biopharmaceutical industryMAMMass spectrometryProteomicsTherapeutic protein production

Substanzen

Recombinant ProteinsBiological ProductsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Center for Genetic Engineering and Biotechnology, PO Box 6162, La Habana, Cuba. Electronic address: gpadronpalomares@gmail.com.

Zitieren

APA

Padrón, G. (2026). Proteomics in biopharmaceutical industries. Journal of Proteomics, 328, 105646. https://doi.org/10.1016/j.jprot.2026.105646

Vancouver

Padrón G. Proteomics in biopharmaceutical industries. Journal of Proteomics. 2026;328:105646. doi:10.1016/j.jprot.2026.105646

BibTeX
@article{Padrn2026,
  author = {Padrón, Gabriel},
  title = {Proteomics in biopharmaceutical industries},
  journal = {Journal of Proteomics},
  year = {2026},
  volume = {328},
  pages = {105646},
  doi = {10.1016/j.jprot.2026.105646}
}
Kostenlos starten →